JPRN-UMIN000023101已完成未知
[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseases - [C-11]Acetate PET/CT study
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •i. serum glucose level greater than 200mg/dl ii. pregnancy or possible iii. patients can't demonstrate informed consent iv. early gastric cancer in which [F-18]FDG PET/CT isn't applicable for covered health insurance
研究者
相似试验
已完成
Unknown
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.Advanced or recurrent lung cancerJPRN-UMIN000053550iigata University Medical and Dental Hospital165
已完成
不适用
Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.ovarian cancerNL-OMON29961Academisch Ziekenhuis Maastricht20
进行中（未招募）
1 期
Study to see if new research scans can show how treatment affects the blood supply to kidney cancersPrimary and metastatic cancer. The active substance is a diagnostic agent that identifies angiogenesis associated with tumour growth.MedDRA version: 14.1 Level: PT Classification code 10050018 Term: Renal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10038389 Term: Renal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002833-20-GBOxford University Hospitals NHS Trust10
已完成
不适用
11C-MET PET(/CT) vs 18F-FDG PET(/CT) in the follow-up of differentiated thyroid cancer*NL-OMON32909niversitair Medisch Centrum Groningen40
尚未招募
不适用
Management and prognosis of breast cancer through FDG PET/CTCTRI/2012/09/002966ot applicable Thesis Protocol500